lateral flow test
MHRA confirms registration of Avacta’s lateral flow test
June 7, 2021Sales and Marketing COVID-19, EU, MHRA, lateral flow test
Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
